American Society of Hematology
Explore special articles published online first to coincide with presentations at American Society of Hematology.
Related Articles
Luspatercept/Lenalidomide Combo Demonstrates Safety and Early Efficacy in Lower-Risk, Non-Del(5q) MDS
Lenalidomide plus luspatercept demonstrated safety, tolerability, and efficacy in patients with non-del(5q) myelodysplastic syndrome.
WT-7 Shows Acceptable Safety Profile in Relapsed/Refractory T-ALL/LBL
Armin Ghobadi, MD, discusses the safety profile of WT-7 in heavily pretreated relapsed/refractory T-ALL and LBL.
Exploring CAR-T Therapy in Early Lines of Relapsed/Refractory Multiple Myeloma
Panelists discuss the data surrounding the use of CAR-T therapy in earlier lines of treatment for relapsed/refractory multiple myeloma (R/R MM), including findings from the…
Regulation of CAR T cell exhaustion and effects of IL-4
Stewart CM, Siegler EL, Sakemura RL, et al. IL-4 Drives Exhaustion of CD8-Positive CART Cells. Nature Communications. 2024; (doi: 10.1038/s41467-024-51978-3). Researchers say interleukin 4…
TACE Plus Camrelizumab/Rivoceranib Extends PFS in Unresectable Liver Cancer
Additionally, data show a trend towards improved overall survival with TACE plus camrelizumab/rivoceranib in the phase 2 CARES-005 study.
Second-Line Ropeginterferon Alfa-2b Boosts Responses in Essential Thrombocythemia
Ropeginterferon alfa-2b improved responses in patients with essential thrombocythemia with resistance or intolerance to hydroxyurea.
Neuroinflammation, Stress-Related Suicidal Ideation, and Negative Mood in Depression
This cross-sectional study evaluates associations between neuroinflammation and stress-related suicidal ideation, negative affect, and history of suicidal behavior.
Doxycycline Postexposure Prophylaxis to Prevent Bacterial Sexually Transmitted Infection
This JAMA Guidelines Synopsis summarizes the 2024 Centers for Disease Control and Prevention guidelines on use of doxycycline postexposure prophylaxis (doxyPEP) for bacterial sexually transmitted…
Dapsone ‘Should Be Considered’ as Pediatric ITP Treatment, Research Shows | Docwire News
Dapsone demonstrates efficacy and acceptable safety with low costs as treatment for pediatric ITP.